Study guide
1.2 Quality Systems, Quality Control, and Westgard Rules Interpretation
AMT Medical Laboratory Scientist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: General Laboratory Operations, Safety & Quality
1.1 Laboratory Safety, OSHA Standards, Hazard Communication, and Biohazard Control 1.2 Quality Systems, Quality Control, and Westgard Rules Interpretation 1.3 Specimen Collection, Handling, Order of Draw, and Phlebotomy Complications 1.4 Laboratory Instrumentation, Photometry, Spectrophotometry, and Centrifugation 1.5 Laboratory Mathematics, Dilutions, Solution Preparation, and Standard Curves 1.6 Regulatory Compliance, CLIA '88 Regulations, Accreditation, and Laboratory Ethics
2 Chapter 2: Clinical Chemistry & Metabolic Testing
2.1 Carbohydrate Metabolism, Glucose Regulation, Diabetes Mellitus, and HbA1c 2.2 Proteins, Non-Protein Nitrogenous Compounds (BUN, Creatinine, Uric Acid), and Renal Function 2.3 Enzymology and Organ Systems 2.4 Electrolytes, Acid-Base Balance, Anion Gap, and Blood Gas Analysis 2.5 Clinical Endocrinology, Thyroid, Adrenal, and Reproductive Hormones 2.6 Clinical Toxicology, Therapeutic Drug Monitoring (TDM), and Pharmacokinetics 2.7 Lipids, Lipoproteins, and the Friedewald LDL Calculation
3 Chapter 3: Hematology & Leukocyte Disorders
3.1 RBC Indices and Anemia 3.2 WBC Differential and Benign Disorders 3.3 Hematologic Malignancies 3.4 Hemoglobin Structure, Hemoglobinopathies (Sickle Cell, Thalassemia), and Variants 3.5 Hematology Automation, Flow Cytometry, and Cell Counting Technology
4 Chapter 4: Coagulation & Hemostasis
4.1 Primary and Secondary Hemostasis, Platelet Function, and Vascular Integrity 4.2 Coagulation Cascade Disorders 4.3 Coagulation Testing and Anticoagulants
5 Chapter 5: Immunology & Serology
5.1 Immune Mechanisms, Hypersensitivity Reactions, and Autoimmune Disease Testing 5.2 Serological Testing Principles and Infectious Serology
6 Chapter 6: Immunohematology & Blood Grouping
6.1 ABO and Rh Blood Group Systems, Antigens, Subgroups, and Weak D Variant 6.2 Red Cell Antibody Screening, Identification Panels, and Dosage Effects 6.3 Direct and Indirect Antiglobulin Testing (DAT/IAT) and Troubleshooting 6.4 Compatibility Testing, Crossmatching, and Hemolytic Disease of the Fetus and Newborn
7 Chapter 7: Blood Banking & Transfusion Medicine
7.1 Blood Donor Selection, Screening, Collection, and Component Storage 7.2 Transfusion Practice, Indications for Blood Components, and Administration 7.3 Transfusion Reactions: Investigation Protocol and Reaction Classification
8 Chapter 8: Clinical Microbiology
8.1 Specimen Processing, Gram Stain, and Aerobic Gram-Positive Cocci 8.2 Gram-Negative Bacilli: Enterobacteriaceae, Non-Fermenters, and Fastidious Organisms 8.3 Anaerobic Bacteria, Mycobacteria, Acid-Fast Stains, and Molecular Diagnostic Methods 8.4 Clinical Mycology and Medical Parasitology 8.5 Antimicrobial Susceptibility Testing, Resistance, and Virology
9 Chapter 9: Urinalysis & Body Fluids
9.1 Physical and Chemical Examination of Urine and Reagent Strip Principles 9.2 Microscopic Urinalysis: Cells, Casts, Crystals, and Renal Pathology 9.3 Analysis of Cerebrospinal Fluid (CSF), Serous Fluids, and Synovial Fluid
1.2 Quality Systems, Quality Control, and Westgard Rules Interpretation
Key Takeaways Explain This Topic AI
Quality Assurance (QA) monitors the entire testing pathway (pre-analytical, analytical, post-analytical), whereas Quality Control (QC) focuses solely on the analytical phase.
The Coefficient of Variation (CV%) is calculated as (SD / Mean) x 100 and serves as an index of precision; lower CV% indicates higher precision.
A shift represents an abrupt, continuous change in the mean (e.g., new reagent lot), while a trend is a gradual, progressive drift (e.g., degrading light source).
The Westgard 1-2s rule is purely a warning rule, whereas 1-3s, 2-2s, R-4s, 4-1s, and 10-x are mandatory rejection rules that require corrective action.
Random error (e.g., pipetting bubbles, voltage spikes) affects precision, while systematic error (e.g., miscalibration, reagent degradation) affects accuracy.
Last updated: July 2026
Quality Assurance (QA) and Quality Control (QC) are the bedrock of clinical laboratory testing, ensuring that the results reported are accurate, reliable, and clinically useful. While these terms are sometimes used interchangeably, they represent distinct concepts in laboratory management.
Quality Assurance (QA) is a comprehensive, overarching system that monitors all aspects of the laboratory's operations. It encompasses the entire testing pathway: the pre-analytical phase (patient preparation, specimen collection, transport), the analytical phase (instrument calibration, reagent integrity, maintenance), and the post-analytical phase (result reporting, critical value notification, data interpretation). QA is proactive, aiming to prevent errors before they occur.
Quality Control (QC) is a specific, quantitative subset of QA focused solely on the analytical phase. It involves the regular assaying of control materials alongside patient samples to verify that an analytical process is functioning correctly. Control materials must mimic patient samples in matrix and have known, predetermined target values.
Statistical Foundations of QC
To interpret QC data, laboratorians rely on fundamental statistical metrics derived from a Gaussian (normal) distribution.
Mean: The arithmetic average of a set of data points, representing the target value of the control.
Standard Deviation (SD): A measure of the dispersion or spread of data around the mean. In a normal distribution, approximately 68.2% of values fall within +/- 1 SD, 95.5% within +/- 2 SD, and 99.7% within +/- 3 SD. Clinical labs universally establish a +/- 2 SD range as the acceptable limit for a control result, representing a 95% confidence interval.
Coefficient of Variation (CV%): An index of precision, normalizing the standard deviation relative to the mean. It is calculated as: CV% = (SD / Mean) x 100 . A lower CV% indicates greater precision. Ideally, laboratory assays strive for a CV of less than 5%.
Accuracy vs. Precision
Understanding the distinction between accuracy and precision is a classic exam concept, often visualized using a target analogy.
Accuracy: How close the measured value is to the true or accepted value (hitting the bullseye). Poor accuracy reflects systematic error .
Precision: How closely repeated measurements of the same sample agree with each other (hitting the same spot repeatedly, even if not the bullseye). Poor precision reflects random error .
Reliability: The combination of both accuracy and precision. An assay must be reliable to be clinically valid.
Types of Analytical Errors
Random Error: Fluctuations that occur without a predictable pattern. Affects precision. Causes include air bubbles in reagent lines, electrical voltage surges, improper pipetting technique, or fluctuations in temperature.
Systematic Error: A continuous, unidirectional shift away from the true value. Affects accuracy. It can be seen as a shift or a trend on a Levey-Jennings chart. Causes include degrading reagents, a failing light source, or a calibration shift.
Shift: An abrupt, sudden change in the mean that becomes continuous (e.g., installing a new, miscalibrated lot of reagent).
Trend: A gradual, progressive drift of QC values in one direction over several days (e.g., gradual deterioration of a reagent or a slowly failing lamp).
Levey-Jennings Charts and Westgard Multirule System
QC data is visually tracked using a Levey-Jennings (L-J) chart, which plots daily control values against the established mean and SD limits. To interpret L-J charts systematically and decide whether to accept or reject an analytical run, clinical laboratories utilize the Westgard Multirule System .
Dr. James Westgard developed these rules to optimize error detection while minimizing false rejections. It is crucial for the exam to differentiate between a warning rule and a rejection rule, and to identify whether a rule indicates random or systematic error.
Westgard Rule Definition Action Error Type
1-2s One control observation exceeds the +/- 2 SD limit. Warning. Prompts inspection, but the run is accepted if no other rules are violated. N/A (Screening rule)
- 1-3s One control observation exceeds the +/- 3 SD limit. Reject run. Random Error
- 2-2s Two consecutive control observations exceed the same +2 SD or -2 SD limit. Reject run. Systematic Error
R-4s One control exceeds +2 SD and another exceeds -2 SD within the same run (range >4 SD). Reject run. Random Error
- 4-1s Four consecutive observations exceed the same +1 SD or -1 SD limit. Reject run. Systematic Error
- 10-x Ten consecutive control observations fall on the same side of the mean. Reject run. Systematic Error
Exam Trap: The R-4s rule only applies within a single run . It cannot be applied across different days or different runs. If the low control is -2.1 SD and the high control is +2.2 SD in the morning run, the R-4s rule is violated.
When a rejection rule is violated, patient results cannot be reported. The technologist must troubleshoot the assay, document the corrective action (e.g., recalibration, changing reagents), run the controls again, and verify they are within acceptable limits before releasing patient data.
Diagnostic Efficacy (Sensitivity and Specificity)
Beyond internal QC, a laboratory must evaluate the clinical utility of a test.
Diagnostic Sensitivity: The ability of a test to correctly identify individuals who have the disease (True Positives). High sensitivity assays are used for screening because they have few false negatives. Formula: TP / (TP + FN) x 100.
Diagnostic Specificity: The ability of a test to correctly identify individuals who do not have the disease (True Negatives). High specificity assays are used for confirmation because they have few false positives. Formula: TN / (TN + FP) x 100.
Positive Predictive Value (PPV): The probability that a positive test result actually means the patient has the disease. Strongly influenced by disease prevalence.